Search

Your search keyword '"Nickoloff, Brian J."' showing total 958 results

Search Constraints

Start Over You searched for: Author "Nickoloff, Brian J." Remove constraint Author: "Nickoloff, Brian J."
958 results on '"Nickoloff, Brian J."'

Search Results

1. 495 - Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis

2. 732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations.

5. Data from A Phase 2a Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer

6. Data from Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma

7. Supplementary Figure S1 from Loss of Inositol Polyphosphate 5-Phosphatase Is an Early Event in Development of Cutaneous Squamous Cell Carcinoma

8. Data from Loss of Inositol Polyphosphate 5-Phosphatase Is an Early Event in Development of Cutaneous Squamous Cell Carcinoma

9. Supplementary Figure 1 from Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma

10. Supplementary Figure 2 from Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma

11. Supplementary Figure 4 from Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma

12. Supplementary Figure Legend from Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma

13. Perspective on this Article from A Phase 2a Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer

14. Supplementary Figure 3 from Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma

15. Supplementary Figure 2 from Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation

17. Supplementary Table 1 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes

18. Supplementary Figure S3 from Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma Cells

19. Supplementary Figure 1 from Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation

20. Supplementary Figure 4 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

21. Data from Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation

23. Supplementary Figure 6 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

24. Supplementary Figure 3 from Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation

25. Supplementary Figure 4 from Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation

26. Supplementary Table 1 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

27. Supplementary Figure 5 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

28. Supplementary Figure 3 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

29. Supplementary Methods and Materials, Figure Legends 1-7 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

30. Data from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes

31. Supplementary Methods and Materials from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes

33. Supplementary Figure 1 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes

35. Supplementary Figure Legends 1-2 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes

37. Supplementary Figure 7 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

38. Supplementary Table 1 from Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation

42. Supplementary Figure 5 from Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation

43. Supplementary Figure 2 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes

44. Supplementary Figure 1 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

45. Data from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

47. Supplementary Figure 2 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

Catalog

Books, media, physical & digital resources